Advanced Cell Diagnostics Raises $12M in Series B Round | GenomeWeb

NEW YORK (GenomeWeb News) – Advanced Cell Diagnostics today said that it completed its $12 million Series B equity financing round to support the commercial expansion of its RNA biomarker technology.

New Leaf Venture Partners and existing investor Morningside Ventures participated in the round.

The funding will go toward further commercialization of Advanced Cell's RNAscope-based products and services into the life science research market, as well as toward acceleration of RNAscope into the clinical diagnostics space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.